Koers Quest PharmaTech Inc Toronto S.E.
Aandelen
QPT
CA74836M1068
Biotechnologie & Medisch Onderzoek
Omzet 2023 | - | Omzet 2024 | - | Marktkapitalisatie | 4,23 mln. 5,79 mln. 3,87 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -7 mln. -9,58 mln. -6,4 mln. | Nettowinst (verlies) 2024 | -3 mln. -4,11 mln. -2,74 mln. | EV/omzet 2023 | - |
Nettoschuld 2023 | 625K 856K 572K | Nettoschuld 2024 | 283K 387K 259K | EV/omzet 2024 | - |
K/w-verhouding 2023 |
-1,61
x | K/w-verhouding 2024 |
-1,4
x | Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 |
-
| Vrij verhandelbaar | 82,88% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 17-06-04 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 01-01-05 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 17-06-04 | |
J. Lievonen
CHM | Chairman | - | 05-07-21 |
Jeffrey Shon
BRD | Director/Board Member | - | 05-07-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+24,74% | 47,96 mld. | |
-0,47% | 42,45 mld. | |
+43,96% | 41,47 mld. | |
+25,40% | 31,6 mld. | |
+17,96% | 28,63 mld. | |
-4,47% | 28,03 mld. | |
+50,73% | 14,56 mld. | |
+42,56% | 14,14 mld. | |
+1,46% | 12,58 mld. |